Key Financial Data Of Reporting Company

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7731850

Concept 2017-07-01 to
2017-09-30
2017-04-01 to
2017-09-30
As at
2017-09-30
2016-04-01 to
2017-03-31
As at
2017-03-31
2016-07-01 to
2016-09-30
2016-04-01 to
2016-09-30
As at
2016-09-30
Key financial data of reporting company
Business results of reporting company
Net sales
49,860,000,000 JPY
101,479,000,000 JPY
52,179,000,000 JPY
Ordinary profit (loss)
15,517,000,000 JPY
30,981,000,000 JPY
16,238,000,000 JPY
Net assets
108,406,000,000 JPY
102,655,000,000 JPY
94,736,000,000 JPY
Total assets
148,590,000,000 JPY
135,060,000,000 JPY
131,648,000,000 JPY
Basic earnings (loss) per share
133.74
267.56
536.70
137.95
278.02
Diluted earnings per share
Equity-to-asset ratio
0.730 xbrli:pure
0.760 xbrli:pure
0.720 xbrli:pure
Net cash provided by (used in) operating activities
11,086,000,000 JPY
15,327,000,000 JPY
5,699,000,000 JPY
Net cash provided by (used in) investing activities
-822,000,000 JPY
-3,503,000,000 JPY
-2,151,000,000 JPY
Net cash provided by (used in) financing activities
-6,500,000,000 JPY
-9,800,000,000 JPY
-6,729,000,000 JPY
Cash and cash equivalents
47,530,000,000 JPY
43,767,000,000 JPY
38,562,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.